BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Auspex Pharmaceuticals (ASPX) To Present At The Cowen and Company Healthcare Conference 2/23/2015 7:37:34 AM
Auspex Pharmaceuticals (ASPX) Completes Enrollment In A Pivotal Clinical Trial Of SD-809 In Tardive Dyskinesia 2/3/2015 9:16:39 AM
Auspex Pharmaceuticals (ASPX) To Present At The 2015 Leerink Global Healthcare Conference 2/3/2015 7:52:32 AM
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:42:55 AM
Auspex Pharmaceuticals (ASPX) Announces Pricing Of Follow On Offering 1/23/2015 7:19:53 AM
Auspex Pharmaceuticals (ASPX) Announces Proposed Public Offering Of Common Stock 1/22/2015 7:34:55 AM
Auspex Pharmaceuticals (ASPX) Receives FDA Orphan Drug Designation Of SD-809 For Treatment Of Tourette Syndrome In The Pediatric Population 1/15/2015 7:04:55 AM
Auspex Pharmaceuticals (ASPX) Announces SD-1077 Program For The Potential Treatment Of Parkinson's Disease And Related Movement Disorders 1/12/2015 7:34:41 AM
Auspex Pharmaceuticals (ASPX) Announces Favorable Topline Results From Thorough QT Clinical Trial Of SD-809 1/12/2015 6:59:58 AM
Auspex Pharmaceuticals (ASPX) To Present At The J.P. Morgan Healthcare Conference 1/6/2015 9:48:24 AM
12345